From discovery to treatment: tracing the path of hepatitis E virus
View abstract on PubMed
Summary
This summary is machine-generated.Hepatitis E virus (HEV) causes acute viral hepatitis globally. Understanding HEV genotypes, transmission, and immune responses is crucial for managing infections, especially in vulnerable populations and transplant recipients.
Area Of Science
- Virology
- Hepatology
- Immunology
Background
- Hepatitis E virus (HEV) is a significant global cause of acute viral hepatitis.
- HEV exhibits eight genotypes with varying host specificities (human, animal, or both).
- Immunosuppressed individuals and pregnant women face higher risks of severe HEV infection and complications.
Purpose Of The Study
- To provide a comprehensive overview of HEV spread, genotypes, prevalence, and clinical impact.
- To highlight the role of the immune response in HEV infection outcomes.
- To emphasize the need for further research and clinical attention to HEV.
Main Methods
- Review of existing literature on HEV epidemiology, virology, and clinical manifestations.
- Analysis of diagnostic methods, including HEV RNA and antibody detection.
- Examination of treatment strategies for acute and chronic HEV infections.
Main Results
- HEV infection outcomes depend on host immunity, with T cell, NK cell, and antibody deficiencies correlating with poor prognosis.
- HEV utilizes microRNAs to regulate its replication and modulate host antiviral responses.
- Extrahepatic manifestations, including neurological disorders, can occur alongside liver disease.
Conclusions
- Effective prevention strategies include sanitation improvements and vaccination.
- Management of acute HEV relies on supportive care; chronic cases may be treated with ribavirin and pegylated interferon.
- Further research is essential, particularly for HEV in solid-organ transplant recipients and acute hepatitis cases.

